Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

4.89
Delayed Data
As of 4:00pm ET
 -0.01 / -0.20%
Today’s Change
1.91
Today|||52-Week Range
5.89
+33.24%
Year-to-Date
Seattle Genetics Earnings: Waiting on ECHELON
Feb 13 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close4.90
Today’s open4.87
Day’s range4.79 - 4.95
Volume2,269,989
Average volume (3 months)2,642,542
Market cap$519.8M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+2.42%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VIVOMeridian Bioscience ...-0.25-1.94%
ALRPRBAlere Inc-0.01-0.00%
LNTHLantheus Holdings In...+0.60+4.98%
CLDXCelldex Therapeutics...0.000.00%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts


Search for Jobs